March 23 (Reuters) - Investment firm TOMS Capital

Investment Management has amassed a stake in the Band-Aid maker

Kenvue ( KVUE ) and is pushing the company to consider a full

sale or separation of some assets, Bloomberg News reported on

Sunday, citing people with knowledge of the matter.

It was not immediately clear the extent of the hedge fund's

total stakeholding in Kenvue ( KVUE ).

Kenvue ( KVUE ), previously a part of Johnson & Johnson ( JNJ ),

settled a four-month battle with activist investor Starboard

Value earlier this month by appointing three new directors to

its board as part of an agreement.

Starboard Value built a stake in Kenvue ( KVUE ) in October, sparking

criticism over the lackluster performance in the skin health and

beauty segment, which houses brands such as Neutrogena and

Aveeno.

TOMS Capital declined to comment and Kenvue ( KVUE ) did not

immediately respond to a Reuters request for comment, while a

spokesperson for Kenvue ( KVUE ) told Bloomberg News, "Kenvue's ( KVUE ) board and

management team are committed to acting in the best interests of

the company and all shareholders and we remain focused on

accelerating sustainable, profitable growth and enhancing

shareholder value."